MonoMAC
| MonoMAC | |
|---|---|
| Synonyms | Monocytopenia with Mycobacterial and Fungal Infections, GATA2 deficiency |
| Pronounce | N/A |
| Specialty | Hematology, Immunology |
| Symptoms | Monocytopenia, B-cell and NK cell lymphopenia, Mycobacterial infections, Fungal infections, Pulmonary alveolar proteinosis, Lymphedema, Hearing loss |
| Complications | N/A |
| Onset | Typically in adulthood |
| Duration | Chronic |
| Types | N/A |
| Causes | Genetic mutation in the GATA2 gene |
| Risks | Family history, Genetic predisposition |
| Diagnosis | Genetic testing, Blood tests showing low monocytes, B-cells, and NK cells |
| Differential diagnosis | Severe combined immunodeficiency, Chronic granulomatous disease, HIV/AIDS |
| Prevention | N/A |
| Treatment | Hematopoietic stem cell transplantation, Antibiotics, Antifungals |
| Medication | N/A |
| Prognosis | Variable, depends on treatment and complications |
| Frequency | Rare |
| Deaths | N/A |
MonoMAC is a rare hereditary condition that affects the immune system. It is characterized by a decrease in the number of monocytes, a type of white blood cell that helps fight off infections. This condition also affects other types of white blood cells, including neutrophils, B cells, and natural killer cells. MonoMAC can lead to an increased risk of developing severe, recurrent infections.
Symptoms[edit]
The symptoms of MonoMAC can vary greatly from person to person. Some people may have no symptoms, while others may experience frequent infections, fever, fatigue, and weight loss. In some cases, MonoMAC can lead to the development of myelodysplastic syndrome, a condition that affects the bone marrow's ability to produce blood cells.
Causes[edit]
MonoMAC is caused by mutations in the GATA2 gene. This gene provides instructions for making a protein that plays a crucial role in the development of many cell types, including white blood cells. Mutations in the GATA2 gene disrupt the normal development of these cells, leading to the characteristic features of MonoMAC.
Diagnosis[edit]
Diagnosis of MonoMAC is based on a combination of clinical findings, laboratory tests, and genetic testing. Laboratory tests may show a decrease in the number of monocytes and other white blood cells. Genetic testing can confirm a diagnosis by identifying a mutation in the GATA2 gene.
Treatment[edit]
Treatment for MonoMAC is aimed at managing symptoms and preventing complications. This may include antibiotics to treat infections, blood transfusions to replace blood cells, and in some cases, a bone marrow transplant.
Prognosis[edit]
The prognosis for individuals with MonoMAC can vary. Some people may live relatively normal lives with few complications, while others may experience severe, life-threatening infections. Early diagnosis and treatment can improve the prognosis.
See also[edit]
References[edit]
<references />
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian